期刊文献+

糖尿病前期人群生活行为干预效果分析 被引量:12

下载PDF
导出
摘要 目的探讨综合生活行为干预对糖尿病前期人群血糖和疾病转归的影响。方法将通过健康体检筛选出的210例糖尿病前期患者随机分为对照组和生活方式干预组。对照组仅给予一般健康教育;生活方式干预组给予饮食和运动方式指导。随访2 a。结果干预2 a后,生活方式干预组患者血糖、血压、体质量指数、总胆固醇均明显低于对照组(P<0.05),生活行为习惯有明显改善。生活方式干预组中仅12例(10.9%)发展为糖尿病,而对照组共46例(46.0%)进展为糖尿病。生活方式干预组逆转为正常糖耐量的比例高于对照组(33.6%vs 2.0%)(P<0.05)。结论生活方式干预有助于糖尿病前期人群逐步建立健康的生活行为,降低糖尿病前期人群糖尿病的发生率,增加正常糖耐量的逆转率。
出处 《山东医药》 CAS 北大核心 2011年第41期75-76,共2页 Shandong Medical Journal
基金 山东省软科学研究计划项目(2010RKGA2027)
  • 相关文献

参考文献5

  • 1罗樱樱 纪立农.糖尿病前期人群的识别与管理.中华健康管理学杂志,2007,1:49-50.
  • 2周盛鹏,谢锦桃,刘军,周俊枝.美国糖尿病协会2008糖尿病诊疗指南(上)[J].中国全科医学,2008,11(12):1056-1058. 被引量:78
  • 3Genuth S, Alberti KG, Bennett P, et al. Expert committee on the diagnosis and classification of diabetes mellitus: follow-up reporl on the diagnosis of diabetes mellitus [ J ]. Diabetes Care, 2003,26 ( 11 ) :3160-3167.
  • 4Knowler WC, Barrett-Connor E, Fowler SE, et al. Rcduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J]. N Engl J Med, 2002,346( 1 ) :393-403.
  • 5卢艳慧,陆菊明,王淑玉,李春霖,刘力生,郑润平,田慧,王先令,杨丽娟,张育青,潘长玉.糖尿病前期人群综合强化干预两年后的转归及影响因素[J].中华内分泌代谢杂志,2009,25(1):30-33. 被引量:44

二级参考文献11

  • 1Genuth S, Alberti KG, Bennett P, et al. Expert committee on the diagnosis and classification of diabetes mellitus : follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 2003,26:3160-3167.
  • 2Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 1997,20:537-544.
  • 3Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes prevention program research group reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 2002,346:393- 403.
  • 4Lindstrom J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS) : Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 5Mensink M, Feskens E, Saris WH, et al. Study on lifestyle intervention and impaired glucose tolerance Maastricht (SLIM) : preliminary results after one year. Int J Obes Relat Metab Disord, 2003,27:377-384.
  • 6Chiasson JL, Josse RG, Gomis R, et al. STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus : the STOPNIDDM randomised trial. Lancet, 2002,359:2072-2077.
  • 7Chiasson JL, Jesse RG, Gomis R, group. Acarbose treatment and the et al. STOP-NIDDM trial research risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP- NIDDM trial. JAMA, 2003,290:486-494.
  • 8Li CL, Pan CY, Lu JM, et al. Effect of metformin on patients with impaired glucose tolerance. Diabet Med, 1999,16:477-481.
  • 9Azen SP, Peters RK, Berkowitz K, et al. TRIPOD (TRoglitazone In the Prevention Of Diabetes) : a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. Control Clin Trials, 1998,19:217-231.
  • 10The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet, 2006, 368,1096-1105.

共引文献122

同被引文献124

引证文献12

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部